Micro-x Ltd. · ASX:MX1
Micro-x — 15th Bioshares Biotech Summit 2019
24 slides from Micro-x's conference presentation, Jul 26, 2019
Slide 1: Company Presentation
Micro-X Limited, ABN 21 153 273 735 COMPANY PRESENTATION For personal use only Key updates to Company’s strategies, activities & milestones - 15th Bioshares investment summit in Queenstown, NZ Adelaide, Australia, 26 July 2019: Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company
Slide 2: Setting Course & Scaling up commercial activities
For personal use only Ltd ACN 153 273 735 ASX: MX1 Company Presentation Setting Course & Scaling up commercial activities Bioshares Biotech Summit 2019, Queenstown NZ, 26th July 2019 Peter Rowland Managing Director & CEO
Slide 3: Disclaimer
Disclaimer For personal use only This document contains certain forward-looking statements that involve risks and uncertainties. Although we believe that the expectations reflected in the forward-looking statements are reasonable at this time, we can give no assurance that these expectations will pr
Slide 4: Overview
Overview For personal use only Next generation X-ray for global health and security markets • ASX listed hi-tech X-ray company based in Tonsley, Adelaide • Next generation, cold cathode nano technology enables X-ray products with significant reduction in size, weight and power requirements • greater
Slide 5: Investment Highlights
Investment Highlights For personal use only Advanced technology, design and manufacturing company • Platform technology – health and security applications • Built strong Design and Manufacturing capability & processes • Addressed manufacturing issues with CNT insourcing project • First product, DRX
Slide 6: Next generation X-ray technology
Next generation X-ray technology For personal use only Our carbon nanotube technology provides a revolution in X-ray products & functions Existing X-Ray Technology Next Gen Filament LED Technology unchanged since 1896 CNT emitter + electronic control generates X-ray beam Hot filament generates X-ray
Slide 7: Product roadmap
Product roadmap For personal use only Planned product evolution – from current X-ray uses to solving unmet needs Mobile medical X-ray Mobile medical X-ray Counter terrorism Airport screening for Military IED Detection Nano Rover MBS MBI Launched 2019 Launch late 2020 Prototype ~ 2021 Prototype end 2
Slide 8: Business model & Strategies
Business model & Strategies For personal use only Commercialise our proprietary technology products with selected global partners • Multi-pronged strategy in healthcare, defence and security – based on proprietary technology • World leading in-house design and technology capabilities • Expand highly
Slide 9: Corporate Snapshot
Corporate Snapshot For personal use only Growth stage company with institutional and strategic investor support Share & Trading Statistics (Closing Price on 22 July 2019) Share Price $0.32 per share Total Shares On Issue 158.3 million MX1 - Three month trading $0.40 1.6 Millions Options Issued 13.7
Slide 10: Experienced leadership
Experienced leadership For personal use only Technical and commercial expertise to support our goals and objectives Peter Rowland Patrick O’Brien Yasmin King Dr Alexander Gosling, AM Managing Director & CEO Non-Executive Chairman Non-Executive Director Non-Executive Director Over 30 years’ hi-tech e
Slide 11: DRX Revolution Nano
For personal use only DRX Revolution Nano Our first commercial product - Healthcare © Micro-X Ltd 2019 Company Presentation – July 2019 10
Slide 12: New solution in mobile X-ray for healthcare
New solution in mobile X-ray for healthcare For personal use only Carestream Health is a world leader in mobile X-ray for the healthcare market • Carestream Health Product Overview • FDA approved Class II Medical device appointed global distributor • True mobile X-ray device overcoming limitations o
Slide 13: Two year delay - lessons we have learned
Two year delay - lessons we have learned For personal use only Commercial teething problems we did not anticipate • Quality / yield and reliability issues • Air freight – resolved with new packaging & procedures • XinRay tube – drove a strategic shift to insource a superior emitter • 2017 X-ray Tube
Slide 14: Insourcing & Manufacturing Scale up
Insourcing & Manufacturing Scale up For personal use only Next stage Expansion and vertical integration of tube supply Tonsley Facility, Adelaide • > 1,000 m2 • Capacity for medium term needs of Nano production • Dedicated Rover production • Test facilities for MBI project • Mechanical & electrical
Slide 15: Other products in development
For personal use only Other products in development Rover and Mobile Backscatter Imager © Micro-X Ltd 2019 Company Presentation – July 2019 14
Slide 16: Rover - Second Product in Development
Rover - Second Product in Development For personal use only Mobile X-Ray for NATO Role 2-E Deployed Military Medical Facilities • Armies typically use small Product Overview animal X-ray and Naval vessels • Based on key elements of Nano - FDA approved Class II Medical device use X-ray machines in po
Slide 17: MBI - Third Product in development
MBI - Third Product in development For personal use only Unmanned full assessment of potential IEDs • Bomb disposal technicians face life Product Characteris7cs threatening harm when placing X- • Multi-beam CNT imaging with Backscatter detector – enables one-sided X-ray image ray detector behind the
Slide 18: Future aviation security concepts
Future aviation security concepts For personal use only Next Generation Airport X-Ray screening – ‘high speed’ and ‘self service’ High speed – Airport 3D X-ray conveyor Self service checkpoint X-ray model • Latest ECAC Detection Standards 3 & 4 • Secondary screening at boarding gate • Screen up to 1
Slide 19: Thales partnership & $10m investment
Thales partnership & $10m investment For personal use only Technology partnership with a global leader in defence and aircraft security • $10M investment via convertible loan • $5m cash received July 2019 on completion • Contract design and licensing of Airport Checkpoint Security Imaging • Distribu
Slide 20: Future Product Opportunity
Future Product Opportunity For personal use only Brain Perfusion CT Imaging • Golden hour - time to commence stroke treatment biggest factor in patient care Product Characteris7cs • Multi-beam tomography imaging • Ambulances provide first patient contact – need • Ideal to provide early diagnosis of
Slide 21: Goals & Objectives
For personal use only Goals & Objectives We are now setting course © Micro-X Ltd 2019 Company Presentation – July 2019 20
Slide 22: Milestones - setting our new course
Milestones - setting our new course For personal use only Focused on delivering commercial outcomes for all stakeholders Early US sales of Nano Thales Partnering deal & $5m CY 2019 CY 2020 Beyond Next Stage Facility expansion CNT in-sourcing complete 1H - Build on Nano sales Significant Rover & Nano
Slide 23: Conclusions
Conclusions For personal use only Building commercialisation of next generation X-ray technology • Next generation X-ray platform – health and security markets • Significant technology advantages • smaller, lighter, more mobility, new applications • Strategy and focus on technology development & man
Slide 24: For personal use only
For personal use only ACN 153 273 735 Peter Rowland Managing Director 1284 South Road Tonsley SA 5042 +61 8 7099 3966 admin@micro-x.com